Phase 1 GastroEsophageal Junction (GEJ) Cancer Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

A Study of NX-1607 in Adults With Advanced Malignancies

Gastric CancerNon-small Cell Lung Cancer (NSCLC)Cervical Cancer+11 more

Nurix Therapeutics, Inc.345 enrolled17 locationsNCT05107674

Recruiting

Phase 1Phase 2

T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Gastric CancerGastroEsophageal Junction (GEJ) Cancer

Yonsei University58 enrolled1 locationNCT05894824

Recruiting

Phase 1Phase 2

A Beta-only IL-2 ImmunoTherapY Study

Triple-Negative Breast CancerEsophageal CancerGastric Cancer+34 more

Medicenna Therapeutics, Inc.115 enrolled27 locationsNCT05086692